Evidence map›Paper›PMID 24335899›Full record

ReviewThe Journal of investigative dermatology2014

Fibronectin at select sites binds multiple growth factors and enhances their activity: expansion of the collaborative ECM-GF paradigm.

Jia Zhu, Richard A F Clark

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of investigative dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 143 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Microenvironment-based immunotherapy in oral cancer: a comprehensive review.Medical oncology (Northwood, London, England) · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Unlocking the Potential of Stem Cell Microenvironments In Vitro.Bioengineering (Basel, Switzerland) · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Tumor microenvironment and immunotherapy of oral cancer.European journal of medical research · 2022
    Review
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jia ZhuDepartment of Biochemistry, Stony Brook University, Stony Brook, New York, USA.
Richard A F ClarkDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, New York, USA; Department of Dermatology, Stony Brook University, Stony Brook, New York, USA; Department of Medicine, Stony Brook University, Stony Brook, New York, USA. Electronic address: richard.clark@stonybrook.edu.
Stony Brook University · US

Funding

Mechanistic studies of fibronectin peptide P12: a co-factor of PDGF-BBR21AR063445 · NIAMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI CLARK, RICHARD AUGUST · 2012 to 2013
$376k
NIAMS NIH HHS AR063445NIAMS NIH HHS R21 AR063445
6 · The paper itself

Abstract

Intensive research has demonstrated that extracellular matrix (ECM) molecules and growth factors (GF) collaborate at many different levels. The ability of ECM to modulate GF signals has important implications in tissue formation and homeostasis as well as novel therapies for acute and chronic wounds. Recently, a number of GF-binding sites was identified in fibronectin (FN) and was shown to provide another layer of regulation on GF signaling. Here, we review these new findings on FN interaction with GF in the context of general ways ECM molecules regulate GF signaling.

Indexed as

Gene Expression RegulationAnimalsBinding SitesExtracellular MatrixFibroblastsFibronectinsHomeostasisHumansIntercellular Signaling Peptides and ProteinsPeptidesProtein Interaction Domains and MotifsReceptors, Growth FactorSignal TransductionStress, MechanicalTissue EngineeringWound HealingFibronectinsIntercellular Signaling Peptides and ProteinsPeptidesReceptors, Growth Factor

Identifiers

PMID24335899
PMCPMC3961531
OpenAlexW1994548447

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.